Clinical Trial Update: Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the ACCOST study evaluating candesartan cilexetil in acute stroke. The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: City Hospitals Sunderland NHS Foundation Trust | Conditions: Cerebrovascular Accident, Acute Stroke | Phase 4 | Status: UNKNOWN